執(zhí)照.jpg)
扁塑藤素
分析標(biāo)準(zhǔn)品,HPLC≥98%
pristimerin
CAS號：1258-84-0
分子式：C30H40O4
分子量：464.64
MDL：MFCD01711331
別名：扁蒴藤素;Celastrol-methylether; pristimerine
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20098-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥840.00 | 現(xiàn)貨 |
YJ-B20098-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2100.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點：218-219 ℃
沸點：607.7℃ at 760mmHg
外觀：紅色針狀晶體
溶解性：可溶于甲醇、乙醇、DMSO等有機溶劑
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(8篇)
8. [IF=4.1] Kai-lang Mu et al."Analysis of Chemical Constituents of Miao Ethnomedicine Heiguteng Zhuifeng Huoluo Capsule (HZFC) and the Discovery of Active Substances in the Treatment of Rheumatoid Arthritis."ACS Omega".2024;9(9):10860–10874
7. [IF=9.3] Li Tao et al."Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1."PHARMACOLOGICAL RESEARCH".2024 Mar;201:107091
6. [IF=7.9] QinWei Huang et al."DCTPP1, a Reliable Q-Biomarker for Comprehensive Evaluation of the Quality of Tripterygium Glycoside Tablets Based on Chemical References."PHYTOMEDICINE.2023 Jul;:154972
5. [IF=6.069] Honglin Jia et al."Tumor-Derived PD-L1+ Exosomes with Natural Inflammation Tropism for Psoriasis-Targeted Treatment."BIOCONJUGATE CHEMISTRY.2023;XXXX(XXX):XXX-XXX
4. [IF=2.039] Yingxiang Liu et al."Pristimerin Induces Autophagy‐Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway."Chem Biodivers. 2019 Aug;16(8):e1900325
3. [IF=4.114] Zhao Qun et al."Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo."Cell Death Discov. 2019 Aug;5(1):1-13
2. [IF=4.679] Zhuangzhuang Jiang et al."Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells."Food Chem Toxicol. 2021 Jan;147:111919
1. [IF=5.34] Qun Zhao et al."Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway."Phytomedicine. 2021 Nov;92:153723
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實驗技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實驗服務(wù)及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!
如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實驗技術(shù)服務(wù)：
